Canada | Science and Enterprise

A New England hospital system is assessing with real patients a point-of-care test for Covid-19 viruses that return… https://t.co/kdaawxTrOU
about 8 hours ago
New post on Science and Enterprise: Hospitals Testing Fast Covid-19 Diagnostic https://t.co/Ou6Fk0L4Yb #Science #Business
about 8 hours ago
Results of a clinical trial show contact lenses that focus light on multiple areas of the retina reduce near-sighte… https://t.co/fJkqvINR8w
about 14 hours ago
New post on Science and Enterprise: Muti-Focus Contact Lenses Slow Children’s Myopia https://t.co/mWV1LNbHOW #Science #Business
about 14 hours ago
Could?? ... How Russia’s Rushed Covid-19 Vaccine Could Backfire https://t.co/Sqt4P3jllE
about 17 hours ago

Covid-19 Vaccines, Therapies – 10 August 2020

By Alan, on August 10th, 2020%

Seven new vaccine projects got underway last week, raising the total to 164, with six more vaccines reaching clinical trials now totaling 41. . . . → Read More: Covid-19 Vaccines, Therapies – 10 August 2020

NIH Begins Covid-19 Antibody Trials

By Alan, on August 5th, 2020%

National Institutes of Health is beginning clinical trials of experimental antibody therapies to treat Covid-19 infections in people with symptoms ranging from mild to severe. . . . → Read More: NIH Begins Covid-19 Antibody Trials

Trial Set for Covid-19 Antibodies in Long-Term Care

By Alan, on August 3rd, 2020%

Two companies and NIH are beginning a clinical trial of synthetic antibodies to both treat and prevent Covid-19 infections among people in long-term care. . . . → Read More: Trial Set for Covid-19 Antibodies in Long-Term Care

Covid-19 Vaccines, Therapies – 3 August 2020

By Alan, on August 3rd, 2020%

The numbers of vaccine candidates in development and clinical trials show modest but steady growth, now up to 157 and 35 respectively. . . . → Read More: Covid-19 Vaccines, Therapies – 3 August 2020

Covid-19 Vaccines, Therapies – 27 July 2020

By Alan, on July 27th, 2020%

This week’s chart shows since last Monday more new activity for therapies than vaccines, with 15 new Covid-19 therapies joining the array of treatments in development. . . . → Read More: Covid-19 Vaccines, Therapies – 27 July 2020

Venture Funding Down in 2020, Life Sciences Stay Hot

By Alan, on July 24th, 2020%

For the first half of 2020, venture investing declined compared to 2019, but life science and biotechnology investments continued growing for the year. . . . → Read More: Venture Funding Down in 2020, Life Sciences Stay Hot

Covid-19 Vaccines, Therapies – 20 July 2020

By Alan, on July 20th, 2020%

This week, the data show a sharp jump in new Covid-19 therapy projects, with 17 new treatments reported raising the total to 322. . . . → Read More: Covid-19 Vaccines, Therapies – 20 July 2020

Covid-19 Vaccines, Therapies – 13 July 2020

By Alan, on July 13th, 2020%

This week’s report shows a marked increase in activity on therapies, while the number of vaccines in development and clinical trials increased only slightly. . . . → Read More: Covid-19 Vaccines, Therapies – 13 July 2020

Cannabis Assessed for Pain in Real-World Trial

By Alan, on July 10th, 2020%

A clinical trial in Canada is evaluating medical cannabis products as treatments for chronic pain with participants reporting their experiences online. . . . → Read More: Cannabis Assessed for Pain in Real-World Trial

Covid-19 Vaccines, Therapies – 6 July 2020

By Alan, on July 6th, 2020%

A continuing feature on Science & Enterprise is a weekly status report of vaccines and therapies for Covid-19 by the scientific illustration software company BioRender. . . . → Read More: Covid-19 Vaccines, Therapies – 6 July 2020

Science & Enterprise subscription

Specials

Follow us on Twitter

Guest Posts

Please share Science & Enterprise